Completed NCT04964427
This summary needs review. Please check the official study record and contact the research team for details.
In Roma Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 8 Years to 13 Years
Countries Italy
Sponsor Bambino Gesù Hospital and Research Institute
Condition ADHD Completed NCT05869253
This study is completed in Israel. It focuses on ADHD.
In Tel Aviv Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 6 Years to 12 Years
Countries Israel
Sponsor Tel Aviv University
Condition ADHD Terminated NCT02477748
This study was terminated in the United States and in Israel. It is testing MDX 1400 mg Daily Compared With Placebo for ADHD.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States, Israel
Sponsor Alcobra Ltd.
Condition ADHD Completed NCT03936491
This summary needs review. Please check the official study record and contact the research team for details.
In Taipei Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 18 Years
Countries Taiwan
Sponsor National Taiwan University Hospital
Condition ADHD Completed NCT01022229
This summary needs review. Please check the official study record and contact the research team for details.
In Toronto Why is this study shown? This study is directly about ADHD.
ADHD Other From 6 Years to 12 Years
Countries Canada
Sponsor The Canadian College of Naturopathic Medicine
Condition ADHD Completed NCT00928148
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries
Sponsor Shire
Condition ADHD Completed NCT01269463
This study is completed in the United States. It focuses on ADHD.
In Irvine Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries United States
Sponsor Rhodes Pharmaceuticals, L.P.
Condition ADHD Completed NCT00997984
This study is completed in the United States and in Canada. It focuses on ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries United States, Canada
Sponsor Shire
Condition ADHD Completed NCT01363544
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Amsterdam Why is this study shown? This study is directly about ADHD.
ADHD Drug From 7 Years to 13 Years
Countries Netherlands
Sponsor R. van Mourik
Condition ADHD Completed NCT02489279
This summary needs review. Please check the official study record and contact the research team for details.
In Los Angeles Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 18 Years to 40 Years
Countries United States
Sponsor Think Now Incorporated
Condition ADHD Completed NCT04569058
This summary needs review. Please check the official study record and contact the research team for details.
In Boston Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 9 Years to 17 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition ADHD Completed NCT02226445
This summary needs review. Please check the official study record and contact the research team for details.
In Herning Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 18 Years to 64 Years
Countries Denmark
Sponsor University of Aarhus
Condition ADHD